Sandeep Grover, Promil Redhu, Ritu Nehra, Aseem Mehra, Antonino Carcione
The present study also suggests that patients with schizophrenia perform poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups are comparable in metacognition functioning.
BACKGROUND: The available metacognition scales have not been translated in the Indian population.
AIM: This study aimed to translate the Metacognition Self-Assessment Scale (MSAS) and the Metacognition Questionnaire (MCQ-30) into Hindi and to evaluate the internal consistency and split-half reliability of the Hindi versions. Additional objectives were to compare the metacognitive impairments among schizophrenia patients and healthy controls.
METHODOLOGY: MSAS and MCQ-30 were translated into Hindi using the World Health Organisation guidelines, and the Hindi versions were administered to 100 schizophrenia patients and 117 healthy controls enrolled through convenience sampling.
RESULTS: The Cronbach's alpha of MSAS was 0.949 and 0.899 for the schizophrenia and control groups, respectively. The Cronbach's alpha of MCQ-30 was 0.9 and 0.826, for the schizophrenia and control groups, respectively. Patients with schizophrenia performed poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups were comparable.
CONCLUSIONS: The present study also suggests that patients with schizophrenia perform poorly on MSAS when compared to healthy controls. However, on MCQ-30, both groups are comparable in metacognition functioning.